Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat
Clinical trial NCT05961384 · COMPLETED
Trial details
- NCT number
- NCT05961384
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2022-01-15
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.